Skip to content
Pharmaron
  • 中文
  • Locations
  • Services
    • Laboratory Services
      • Laboratory Chemistry
        • Synthetic Chemistry
          • Nucleosides / Nucleotides
          • Peptides
          • Protein Degraders
          • Library Synthesis
        • Medicinal Chemistry
        • Chemistry for New Modalities
          • Nucleosides / Nucleotides
          • Lipids
          • Antibody-drug Conjugates
        • Radiolabelling and Radiosynthesis
        • Computer-Aided Drug Design
        • Analytical and Purification Sciences
        • DNA-Encoded Libraries
        • Cheminformatics
        • Enabling Technology
      • Biosciences
        • Structural Biology
        • in vitro Biology
          • Cellular Disease Models
        • DMPK
          • DMPK for Discovery & Preclinical Development
            • Discovery in vitro ADMET
            • Discovery in vivo PK
            • Radiolabelled Metabolism and Biodistribution
          • Regulatory DMPK
        • in vivo Pharmacology
          • Animal Disease Models
            • Cardiovascular and Metabolic Diseases Animal Models
            • CNS/PNS Diseases Animal Models
            • Dermal Animal Models
            • Inflammation and Pain Animal Models
            • Medical Devices – Cardiovascular & Metabolic Diseases
            • Oncology Animal Models
            • Ophthalmology Animal Models
          • ex vivo Pharmacology & Biomarkers
          • PK/PD
        • Compound Management
      • Safety Assessment
        • General Toxicology
        • Safety Pharmacology
        • Genetic Toxicology
        • Developmental and Reproductive Toxicology
        • Pathology
        • Specialty Safety Assessment
        • Bioanalysis
      • Integrated Drug Discovery
      • Bioanalysis
        • Small Molecule Bioanalysis
        • Large Molecule Bioanalysis
        • CGT Bioanalysis
        • Carbon-14 Bioanalysis
      • Medical Devices
    • Chemistry, Manufacturing & Controls
      • Small Molecule Drug Substance
        • Discovery Process Chemistry
        • Process Chemistry
          • Enabling Technology
        • Analytical Development and Quality Control
        • Material Science
        • Process Safety and Engineering
        • API Manufacturing
      • Small Molecule Drug Product
        • Formulation Development
        • Analytical Development and Quality Control
        • Drug Product Manufacturing
      • Quality Assurance
      • Regulatory Affairs
    • Clinical Development
      • Integrated Radiolabelled Sciences
        • Radiolabelling and Radiosynthesis
          • Carbon-14 Radiosynthesis
          • Tritium Radiosynthesis
          • GMP Carbon-14 Radiolabelled APIs and IMPs
          • Tritium and Carbon-14 Radiolabels (RadioTag)
        • Non-clinical ADME with Radiolabelled Compounds
          • Radiolabelled in vitro Metabolism Studies
          • in vivo PK Using Radiolabelled Compounds
          • Tissue Distribution with QWBA and mARG
        • Human AME with Radiolabelled Compounds
          • Pharmacokinetics with Radiolabelled Compounds
          • Mass Balance with Radiolabelled Compounds
          • Metabolite Profiling of Radiolabelled Compounds
          • Metabolite Identification with HRMS
          • Drug-drug Interaction (DDI) Studies
        • Disposition of Radiolabelled Biologics
          • Tritium and Carbon-14 Radiolabels (RadioTag)
          • AMS and Carbon-14 Radiolabelled Biologics
        • Accelerator Mass Spectrometry (AMS)
          • Carbon-14 Microtracers
          • Ultra-sensitive AMS
          • Accelerated Carbon-14 Clinical Programs
          • Phase 0 Microdosing
          • Absolute Bioavailability and IV Pharmacokinetics
          • Mass Balance by AMS
          • Metabolite Profiling Using AMS
          • AMS for Carbon-14 Non-clinical Studies
          • Carbon-14 Radiolabels and AMS for Biologics
        • Environmental Metabolism
          • Dermal Penetration Studies
          • Plant and Livestock Metabolism
      • Clinical Development (US)
        • Early Phase Clinical Research
        • 14C Radiolabelled Studies – Human ADME (Macrotracer/Microtracer)
        • Vaccine Development/Infectious Challenge Studies
        • Accelerator Mass Spectrometry
        • Bioanalysis
        • Biometrics
      • Clinical Development (China)
      • Regulatory Affairs
      • Clinical Trial Recruitment
        • Clinical Trial Recruitment (US)
    • Biologics and Cell & Gene Therapy
      • Biologics Laboratory Services
        • Antibody Discovery
        • Protein Science
        • Biologics PK
        • in vivo Pharmacology
        • Safety Assessment
        • Large Molecule Bioanalysis
      • Biologics CDMO
        • Developability Assessment
        • Process Development
        • Analytical Development and Quality Control
        • Pilot Scale Production
        • cGMP Drug Substance Manufacturing
        • cGMP Drug Product Manufacturing
        • Quality Assurance
      • Cell & Gene Therapy Laboratory Services
        • in vitro Assays
        • in vivo Studies
        • Biodistribution and Viral Shedding
        • CGT Bioanalysis
        • CGT Ophthalmology
        • CGT Safety Assessment
      • Gene Therapy CDMO
        • Research Grade, High Quality and GMP Plasmid DNA Manufacturing
        • Viral Vector Process Development
        • Product Characterization and QC Analytics
        • GMP Manufacture and QP Release
        • Regulatory Dossier Authoring and Specification Justification
  • Modalities
    • Small Molecule
    • Biologics
    • Cell and Gene Therapy
  • Stories
  • Knowledge Center
    • Symposiums
    • Chemistry Lecture Series
    • Publications
    • Posters
    • Webinars
    • Podcasts
    • Guides & Whitepapers
  • About Us
    • Overview
    • Leadership
    • Culture
    • Social Responsibility
    • Locations
    • Upcoming Events
    • News
  • Careers
    • Working at Pharmaron
    • Employee Testimonials
    • Job Openings
  • Investors
  • Contact
Contact Us
Home » About Us » Locations » Beijing Headquarters

Beijing Headquarters

Services: Drug Research & Development

Pharmaron's Beijing site features a modern, multi-story office building with a curved façade, set against a clear sky.

Beijing Headquarters Facility Information:

Directions to Beijing Headquarters

  • R&D headquarters
  • Lab supports discovery to preclinical and clinical development by utilizing technology platforms laboratory chemistry, biosciences, CMC and clinical development
  • 1.2 million ft2

Address:
6 Taihe Road, BDA, Beijing, 100176, China
  • Services
    • Laboratory Services
    • Chemistry, Manufacturing & Controls
    • Clinical Development
    • Biologics and Cell & Gene Therapy
  • Knowledge Center
    • Symposiums
    • Chemistry Lecture Series
    • Publications
    • Posters
    • Webinars
    • Podcasts
    • Guides & Whitepapers
  • About Us
    • Overview
    • Leadership
    • Culture
    • Social Responsibility
    • Locations
    • News
  • Modalities
  • Stories
  • Careers
  • Investors
  • Contact Us
© Pharmaron, 2024. All Rights Reserved
  • Data Protection Policy
  • Privacy Policy
  • UK Job Applicant Privacy Policy
  • Site Map
  • Code of Conduct
  • Code of Conduct for Business Partners
  • Modern Slavery Act Statement
  • LinkedIn
  • Twitter